Investors in Lexicon Pharmaceuticals, Inc. (LXRX - Get Report) saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LXRX options chain for the new May 18th contracts and identified the following put contract of particular interest.The put contract at the $8.00 strike price has a current bid of 20 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $8.00, but will also collect the premium, putting the cost basis of the shares at $7.80 (before broker commissions). To an investor already interested in purchasing shares of LXRX, that could represent an attractive alternative to paying $8.36/share today. Because the $8.00 strike represents an approximate 4% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 64%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 2.50% return on the cash commitment, or 17.55% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Lexicon Pharmaceuticals, Inc., and highlighting in green where the $8.00 strike is located relative to that history: The implied volatility in the put contract example above is 118%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $8.36) to be 44%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
How Investors Should Approach the Trade Talks, the Federal Reserve and Micron
United States Secretary of the Treasury Steven Mnuchin made comments on the trade talks early Wednesday. Mnuchin says that he believes that the U.S. and China were almost 90% of the way through trade talks. Fed chair Jerome Powell spoke about the need for the central bank to remain independent and to not cave to "short-term political interests." And, of course, we have Micron MU, which is Real Money's stock of the day and it also released earnings Tuesday after the bell. The company beat expectations.
Ear to the Ground on UTX-Raytheon: What Needs to Happen for the Deal to Close
Shareholders are skittish about this deal, one analyst said. See why they shouldn't be.
AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential
AbbVie's deal for Allergan will give it a new revenue stream in Botox, helping offset potential lower revenue from arthritis drug Humira, which is losing patent protection.
Care.com Shares Slump After Chief Financial Officer Resigns
Care.com's finance chief resigns a few months after a Wall Street Journal report that many day-care centers listed on the company's site were unlicensed.
Dow Ends Down on Mixed Trade Messages From Mnuchin, Trump
Stocks end mixed after Treasury Secretary Steven Mnuchin says the U.S. and China were close to reaching a trade agreement, while President Trump hints that he wants to make a trade deal with Beijing but is happy where things are now.